Topics
High-grade gliomas | Treatment | Targeted therapy | Tislelizumab
Home > Publications > Topics > High-grade gliomas > Treatment > Targeted therapy > Tislelizumab
Wang D, Zhang J, Liu G, Bu C, Wei S, Li M, Lv G, Sheng Z, Mei J,
Yan Z, Gao Y, Zhao R, Shi Y, Wang M, Bu X.
Emotional
distress impairs immune checkpoint blockade efficacy in recurrent
high-grade glioma: Insights from tumor in situ fluid analysis.
Neurooncol
Adv. 2026 Feb 16;8(1):vdag040. doi:
10.1093/noajnl/vdag040. PMID:
41778154. Observational study. ˍ